Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the appointment of Riccardo Butta to the role of president, Americas.

The appointment of a dedicated executive to lead the company’s long-term strategy in the Americas is indicative of the growing regional demand trends and the company’s commitment to broaden its footprint, accelerate its market penetration and improve proximity to its customers in this important region.

“We are excited to welcome Riccardo Butta to Stevanato Group,” said Franco Moro, CEO, Stevanato Group. “We believe the Americas represent a significant growth opportunity for our company, and we are confident that Riccardo’s deep commercial, operational and management expertise will help us strengthen our presence and advance our strategic priorities in this important region.”

Butta joins the group with more than 30 years of management experience, including 20 years with Flex Ltd., a contract development and manufacturing organization (CDMO) with operations spanning 30 countries, including a large presence in the U.S. and Mexico. In his most recent role as senior vice president, Butta was responsible for the global commercial organization of Flex Health Solutions, a business unit of Flex providing contract design, manufacturing, and logistics services to the healthcare industry with a focus on medical devices, drug delivery solutions, and medical/life sciences equipment. During his tenure at Flex, Butta was also responsible for the European organization of Flex Health Solutions, for the global engineering organization focused on medical device development, and for scaling up the Milan medical design center.